Christopher J. McGurk - 17 Feb 2026 Form 4 Insider Report for Cineverse Corp. (CNVS)

Reporting relationship: CEO and Chairman, Director
Issuer ticker: CNVS
Reported as of: 17 Feb 2026
Net transaction value: +$150,000
SEC form: 4
Accepted by SEC: 17 Feb 2026, 21:53:29 UTC
Prior SEC filing: 10 Oct 2025
Next SEC filing: 28 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Christopher J. McGurk

Key filing fact

Christopher J. McGurk filed Form 4 for Cineverse Corp. (CNVS) on 17 Feb 2026.

Key facts

This page summarizes Christopher J. McGurk's Form 4 filing for Cineverse Corp. (CNVS).
1 reported transaction and 6 derivative rows are listed below.
Accepted by SEC: 17 Feb 2026, 21:53.

Change

Previous filing in this sequence was filed on 10 Oct 2025.
Current net transaction value: +$150,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001190283 Primary reporting owner

MCGURK CHRISTOPHER J

Relationship: CEO and Chairman, Director
Address: C/O CINEVERSE CORP., 224 W. 35TH STREET, SUITE 500, #947, NEW YORK
Signature: /s/ Christopher J. McGurk
Signature date: 17 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CNVS transaction

Class A Common Stock

Purchase

Transaction value: $150,000
Shares: +75,000
Change %: +72%
Price: $2.00
Shares after: 178,526
Date: 17 Feb 2026
Ownership: By Christopher and Jamie McGurk Living Trust
Footnotes: F1

CNVS holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 492,519
Date: 17 Feb 2026
Ownership: Direct
Footnotes: F8

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CNVS holding Derivative

Stock Appreciation Right (Right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 35,000
Date: 17 Feb 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 35,000
Exercise price: $29.40
Footnotes: F2

CNVS holding Derivative

Stock Appreciation Right (Right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 125,000
Date: 17 Feb 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 125,000
Exercise price: $10.80
Footnotes: F3

CNVS holding Derivative

Stock Appreciation Right (Right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 125,000
Date: 17 Feb 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 125,000
Exercise price: $9.60
Footnotes: F4

CNVS holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 100,000
Date: 17 Feb 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 100,000
Exercise price
Footnotes: F5

CNVS holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 120,000
Date: 17 Feb 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 120,000
Exercise price
Footnotes: F6

CNVS holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 263,006
Date: 17 Feb 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 263,006
Exercise price
Footnotes: F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

The reporting person is a trustee of the Christopher and Jamie McGurk Living Trust.

Footnote F2

One-third of the stock appreciation rights vested on March 31 of each of 2019, 2020 and 2021.

Footnote F3

62,500 of the stock appreciation rights vested on November 19, 2020 and 62,500 of the stock appreciation rights vested on March 31, 2023.

Footnote F4

Of the stock appreciation rights, 41,666 vested on April 1, 2023, 41,666 vested on April 1, 2024 and 41,668 vested on April 1, 2025.

Footnote F5

Each restricted stock unit has a value equal to one share of Class A common stock. Of such RSUs, 50,000 vest on April 25 of each of 2025, 2026 and 2027.

Footnote F6

Each restricted stock unit has a value equal to one share of Class A common stock. Of such RSUs, 40,000 vest on May 1 of each of 2026, 2027 and 2028.

Footnote F7

Each restricted stock unit has a value equal to one share of Class A common stock. Of such RSUs, 87,669 vest on October 8 of each of 2026 and 2027 and 87,668 vest on October 8, 2028.

Footnote F8

Includes 100,000 shares of restricted stock that vest as follows: 50,000 vest on April 25 of each of 2026 and 2027.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .